CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 62 enrolled
Drug / intervention
Zolidd One ExHex +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03283241
NCT03283241N/ACompleted
CompareCT.gov

A Randomized, Multicentre, Double Blind, Parallel Study to Evaluate the Performance and Safety of the Zolidd One ExHex Dental Implant Compared to Uncoated One ExHex Dental Implant in Subjects With Partial Edentulism

Addbio AB·interventional·Posted Sep 14, 2017·Updated Mar 22, 2022

In Brief

A clinical study evaluating Zolidd One ExHex and One ExHex for Partial Edentulism. Completed, enrolled 62 participants across 3 sites.

Detailed Summary

A randomised, multicentre, double blind, parallel group comparative investigation where subjects will be randomised to receive coated or uncoated implants

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPartial Edentulism
CountriesSweden
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 14, 2017
Enrollment StartSep 1, 2017
Primary CompletionJul 30, 2020
Study CompletionOct 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 8.8 years ago

Interventions

Zolidd One ExHexdevice

Subject will be treated/implanted at visit 2, one of the implants will be chosen as the "index implant"and will be followed together with other implants (maximum 6 implant per subject) at week 8,12 and month 12 and 24.

One ExHexdevice

Subject will be treated/implanted at visit 2, one of the implants will be chosen as the "index implant"and will be followed together with other implants (maximum 6 implant per subject) at week 8,12 and month 12 and 24.